Institutional Ownership
Amphastar Pharmaceuticals In
CUSIP 03209RAB9NOTE 2.000% 3/1AMPH.2.03/15/29Q1 2026
Earnings
Quarterly EPS and revenue are sourced from SEC XBRL financial statements. We ingest the top issuers first; this fills in as coverage expands (or this security isn't mapped to an SEC filer yet).